We are investigating Asterias Biotherapeutics, Inc. (AST) regarding its sale to BioTIme, Inc. for 0.71 shares in BioTime for every share in Asterias.
We are investigating Asterias Biotherapeutics, Inc. (AST) regarding its sale to BioTIme, Inc. for 0.71 shares in BioTime for every share in Asterias.